European Perspectives
European Perspectives on Advances in HIV Treatment

Released: February 17, 2023

Expiration: February 16, 2024

Alexandra Calmy
Alexandra Calmy, MD, FMH, PhD
Jurgen Rockstroh
Jurgen Rockstroh, MD

Activity

Progress
1
Course Completed

In this episode, 2 European HIV experts share their thoughts on some of the most important new antiretroviral therapy insights from HIV research over the past year.

Specifically, the faculty discuss findings from real-world and long-term studies of 2-drug oral regimens, the latest on 2-drug long-acting injectable therapy, how 2-drug options fit into rapid start strategies, and other new and emerging innovations in HIV treatment, including the availability of lenacapavir for multidrug-resistant HIV treatment and resumption of islatravir clinical development.